Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 9, 2019 Off

Verastem Oncology Reports First Quarter 2019 Financial Results

By BusinessWire

Company Reports $1.7 Million in Net Product Revenues from COPIKTRA™; Issues Product Revenue Guidance for 2019 Cash, Cash Equivalents and…

May 9, 2019 Off

NovaBay Pharmaceuticals Reports First Quarter 2019 Financial Results

By BusinessWire

Conference call begins today at 4:30 p.m. Eastern time EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company…

May 9, 2019 Off

Dicerna™ Reports First Quarter 2019 Financial and Operating Results and Provides Corporate Update

By BusinessWire

— Initiated Screening of Participants to Enroll in the PHYOX™2 Phase 2 Pivotal Trial of DCR-PHXC for the Treatment of…

May 9, 2019 Off

Deciphera Pharmaceuticals, Inc. Announces First Quarter 2019 Financial Results

By BusinessWire

– Top-line Data from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Fourth-line and Fourth-line Plus GIST Patients Expected…

May 9, 2019 Off

BioTime Reports First Quarter 2019 Financial Results and Provides Business Update

By BusinessWire

Positive OpRegen® Data Presented at Association for Research in Vision and Ophthalmology Annual Meeting Announced Issuance of New Patent for…

May 9, 2019 Off

Omeros Corporation Reports First Quarter 2019 Financial Results

By BusinessWire

– Conference Call Today at 4:30 p.m. ET – SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to…

May 9, 2019 Off

Synlogic Reports First Quarter 2019 Financial Results and Provides Business Update

By BusinessWire

– Company will host a conference call and webcast at 5:00 pm ET today – CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24SYBX&src=ctag" target="_blank"gt;$SYBXlt;/agt;…

May 9, 2019 Off

Vaxart Announces First Quarter 2019 Financial Results and Provides Corporate Update

By BusinessWire

– $13 million raised in 1H19 – – Norovirus bivalent vaccine Phase 1b clinical study underway with results expected in…

May 9, 2019 Off

Noveome Biotherapeutics, Inc. Announces Publication of Further Preclinical Results Supporting the Neuroprotective Properties of ST266 in Retinal Ganglion Cells

By BusinessWire

PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular…

May 9, 2019 Off

Spectrum Pharmaceuticals Reports First Quarter 2019 Financial Results and Pipeline Update

By BusinessWire

Topline results in the previously treated EGFR cohort (cohort 1) of the poziotinib ZENITH20 trial are expected in Q4 2019.…

Posts pagination

Previous 1 … 3,204 3,205 3,206 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine